These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22544338)

  • 1. Do pure squamous cell carcinomas and urothelial carcinomas have similar prognosis after radical cystectomy?
    Balci U; Ozer K; Gorgel SN; Sefik E; Girgin C; Dincel C
    World J Urol; 2013 Oct; 31(5):1177-82. PubMed ID: 22544338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer.
    Gordetsky JB; Montgomery KW; Giannico GA; Rais-Bahrami S; Thapa P; Boorjian S; Frank I; Cheville J
    Int J Surg Pathol; 2022 Feb; 30(1):6-14. PubMed ID: 34180731
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.
    Martin JW; Vernez SL; Lotan Y; Abdelhalim A; Dutta R; Shokeir A; Abol-Enein H; Mosbah A; Ghoneim M; Youssef RF
    World J Urol; 2018 Nov; 36(11):1835-1843. PubMed ID: 29761225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
    J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy.
    Ehdaie B; Maschino A; Shariat SF; Rioja J; Hamilton RJ; Lowrance WT; Poon SA; Al-Ahmadie HA; Herr HW
    J Urol; 2012 Jan; 187(1):74-9. PubMed ID: 22088332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
    Abdollah F; Sun M; Jeldres C; Schmitges J; Thuret R; Djahangirian O; Tian Z; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    BJU Int; 2012 Feb; 109(4):564-9. PubMed ID: 21810161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?
    Rodler S; Buchner A; Ledderose ST; Eismann L; Volz Y; Pfitzinger P; Kretschmer A; Schulz GB; Karl A; Schlenker B; Stief CG; Jokisch F
    World J Urol; 2021 Jul; 39(7):2537-2543. PubMed ID: 33084922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis.
    Wang JK; Boorjian SA; Cheville JC; Kim SP; Tarrell RF; Thapa P; Frank I
    World J Urol; 2012 Dec; 30(6):801-6. PubMed ID: 23132611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
    Minato A; Noguchi H; Tomisaki I; Fukuda A; Kubo T; Nakayama T; Fujimoto N
    Cancer Control; 2018; 25(1):1073274818800269. PubMed ID: 30213195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
    Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
    Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes?
    Kotb AF; Kovac E; Kassouf W; Chin J; Fradet Y; Izawa J; Estey E; Fairey A; Rendon R; Cagiannos I; Lacombe L; Lattouf JB; Bell D; Drachenberg D; Aprikian AG
    World J Urol; 2012 Dec; 30(6):761-7. PubMed ID: 22293934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of squamous cell transformation on the prognosis of patients treated with radical nephroureterectomy.
    Huang LH; Chen CS; Li JR; Chiu KY; Wang SS; Yang CK; Cheng CL; Lin CC; Ou YC
    BMC Cancer; 2024 Feb; 24(1):247. PubMed ID: 38388388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?
    Kaimakliotis HZ; Monn MF; Cary KC; Pedrosa JA; Rice K; Masterson TA; Gardner TA; Hahn NM; Foster RS; Bihrle R; Cheng L; Koch MO
    Urol Oncol; 2014 Aug; 32(6):833-8. PubMed ID: 24954925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of squamous histology in bladder cancer: a population-based study.
    Izard JP; Siemens DR; Mackillop WJ; Wei X; Leveridge MJ; Berman DM; Peng Y; Booth CM
    Urol Oncol; 2015 Oct; 33(10):425.e7-13. PubMed ID: 26199176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
    Lughezzani G; Sun M; Jeldres C; Alasker A; Budäus L; Shariat SF; Latour M; Widmer H; Duclos A; Jolivet-Tremblay M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Feb; 75(2):376-81. PubMed ID: 20022091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.